ES2402782T8 - Cristal novedoso de ácido fenilalcanoico sustituido y procedimiento de preparación - Google Patents

Cristal novedoso de ácido fenilalcanoico sustituido y procedimiento de preparación Download PDF

Info

Publication number: ES2402782T8
Authority: ES; Spain
Prior art keywords: substituted; preparation procedure; novel crystal; phenylalcanoic; acid
Prior art date: 2006-07-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

ES07790690T

Other languages

English (en)

Other versions

ES2402782T3 (es

Inventor

Yuichi Arimoto

Naoyuki Ishii

Motoshi Shoda

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Asahi Kasei Pharma Corp

Original Assignee

Asahi Kasei Pharma Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-07-20

Filing date

2007-07-12

Publication date

2013-06-10

2007-07-12 Application filed by Asahi Kasei Pharma Corp filed Critical Asahi Kasei Pharma Corp

2013-05-08 Application granted granted Critical

2013-05-08 Publication of ES2402782T3 publication Critical patent/ES2402782T3/es

2013-06-10 Publication of ES2402782T8 publication Critical patent/ES2402782T8/es

Status Active legal-status Critical Current

2027-07-12 Anticipated expiration legal-status Critical

Links

239000002253 acid Substances 0.000 title 1
239000013078 crystal Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Transplantation (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

ES07790690T 2006-07-20 2007-07-12 Cristal novedoso de ácido fenilalcanoico sustituido y procedimientos de preparación Active ES2402782T3 (es)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2006197637		2006-07-20
JP2006197637		2006-07-20
PCT/JP2007/063896 WO2008010448A1 (en)	2006-07-20	2007-07-12	Novel crystal of substituted phenylalkanoic acid and production process

Publications (2)

Publication Number	Publication Date
ES2402782T3 ES2402782T3 (es)	2013-05-08
ES2402782T8 true ES2402782T8 (es)	2013-06-10

Family

ID=38956781

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ES07790690T Active ES2402782T3 (es)	2006-07-20	2007-07-12	Cristal novedoso de ácido fenilalcanoico sustituido y procedimientos de preparación

Country Status (12)

Country	Link
US (4)	US7560478B2 (es)
EP (2)	EP2045244B1 (es)
JP (2)	JP5137834B2 (es)
KR (3)	KR101322116B1 (es)
CN (2)	CN102690234B (es)
AU (2)	AU2007274477B2 (es)
CA (3)	CA2659471C (es)
DK (1)	DK2045244T3 (es)
ES (1)	ES2402782T3 (es)
MX (1)	MX2009000448A (es)
PT (1)	PT2045244E (es)
WO (1)	WO2008010448A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX2010007632A (es)	2008-01-18	2010-08-03	Asahi Kasei Pharma Corp	Composicion farmaceutica estable.
CN104710365A (zh)	2008-04-28	2015-06-17	旭化成制药株式会社	苯丙酸衍生物及其用途
GB202011823D0 (en) *	2020-07-30	2020-09-16	Givaudan Sa	Method

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0495025A (ja)	1990-08-08	1992-03-27	Asahi Chem Ind Co Ltd	アルドースリダクターゼ阻害剤
JPH0495049A (ja)	1990-08-08	1992-03-27	Asahi Chem Ind Co Ltd	ビフェニル‐５，５’‐ビス‐アルカン酸誘導体、その製造法およびその用途
US6376546B1 (en)	1997-10-14	2002-04-23	Asahi Kasei Kabushiki Kaisha	Biphenyl-5-alkanoic acid derivatives and use thereof
WO2002020453A1 (en)	2000-09-07	2002-03-14	Kaneka Corporation	Methods for crystallization of hydroxycarboxylic acids
WO2003026572A2 (en)	2001-09-26	2003-04-03	Merck & Co., Inc.	Crystalline forms of ertapenem sodium
ITRM20020016A1 (it)	2002-01-15	2003-07-15	Sigma Tau Ind Farmaceuti	Derivati di acidi fenil(alchil)carbossilici e derivati fenilalchileterociclici dionici, loro uso come medicamenti ad attivita' ipoglicemizza
DE60325830D1 (de) *	2002-02-21	2009-03-05	Asahi Kasei Pharma Corp	Substituiertes phenylalkansäurederivat und dessen verwendung
US6867320B2 (en)	2002-02-21	2005-03-15	Asahi Kasei Pharma Corporation	Substituted phenylalkanoic acid derivatives and use thereof
CA2535665A1 (en) *	2003-08-14	2005-02-24	Asahi Kasei Pharma Corporation	Substituted arylalkanoic acid derivative and use thereof
IL175718A0 (en)	2005-05-18	2007-08-19	Chemagis Ltd	Novel processes for preparing crystalline telmisartan form a by crystallization from dmf

2007
- 2007-07-12 JP JP2008525842A patent/JP5137834B2/ja not_active Expired - Fee Related
- 2007-07-12 MX MX2009000448A patent/MX2009000448A/es active IP Right Grant
- 2007-07-12 PT PT77906907T patent/PT2045244E/pt unknown
- 2007-07-12 CN CN201210179354.8A patent/CN102690234B/zh not_active Expired - Fee Related
- 2007-07-12 KR KR1020087025075A patent/KR101322116B1/ko not_active Expired - Fee Related
- 2007-07-12 CA CA2659471A patent/CA2659471C/en not_active Expired - Fee Related
- 2007-07-12 AU AU2007274477A patent/AU2007274477B2/en not_active Ceased
- 2007-07-12 WO PCT/JP2007/063896 patent/WO2008010448A1/ja not_active Ceased
- 2007-07-12 ES ES07790690T patent/ES2402782T3/es active Active
- 2007-07-12 CN CN2007800270808A patent/CN101490012B/zh not_active Expired - Fee Related
- 2007-07-12 EP EP07790690A patent/EP2045244B1/en not_active Not-in-force
- 2007-07-12 CA CA2820931A patent/CA2820931C/en not_active Expired - Fee Related
- 2007-07-12 DK DK07790690.7T patent/DK2045244T3/da active
- 2007-07-12 KR KR1020137023629A patent/KR101440255B1/ko not_active Expired - Fee Related
- 2007-07-12 CA CA2773177A patent/CA2773177C/en not_active Expired - Fee Related
- 2007-07-12 EP EP13001575.3A patent/EP2620431A1/en not_active Withdrawn
- 2007-07-12 KR KR1020127015425A patent/KR20120084790A/ko not_active Ceased
- 2007-07-19 US US11/826,999 patent/US7560478B2/en not_active Expired - Fee Related
2009
- 2009-06-12 US US12/483,814 patent/US7754752B2/en not_active Expired - Fee Related
2010
- 2010-05-26 US US12/788,061 patent/US7838546B2/en not_active Expired - Fee Related
- 2010-10-05 US US12/898,367 patent/US7935720B2/en not_active Expired - Fee Related
2011
- 2011-02-01 AU AU2011200408A patent/AU2011200408B2/en not_active Ceased
2012
- 2012-10-04 JP JP2012222039A patent/JP5550696B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20080070967A1 (en)	2008-03-20
CA2773177C (en)	2013-09-24
AU2007274477A1 (en)	2008-01-24
KR20120084790A (ko)	2012-07-30
JP5550696B2 (ja)	2014-07-16
KR101440255B1 (ko)	2014-09-17
US20110021593A1 (en)	2011-01-27
JP5137834B2 (ja)	2013-02-06
US7560478B2 (en)	2009-07-14
US20090312386A1 (en)	2009-12-17
CN101490012B (zh)	2012-07-18
CN102690234A (zh)	2012-09-26
DK2045244T3 (da)	2013-04-15
KR20080104063A (ko)	2008-11-28
EP2045244A1 (en)	2009-04-08
CA2659471A1 (en)	2008-01-24
CN102690234B (zh)	2014-12-24
US7754752B2 (en)	2010-07-13
CA2820931C (en)	2015-08-18
EP2045244B1 (en)	2013-04-03
JP2013028638A (ja)	2013-02-07
AU2011200408B2 (en)	2011-05-26
US7935720B2 (en)	2011-05-03
CN101490012A (zh)	2009-07-22
AU2007274477B2 (en)	2010-11-25
CA2773177A1 (en)	2008-01-24
KR101322116B1 (ko)	2013-10-25
CA2659471C (en)	2012-06-12
JPWO2008010448A1 (ja)	2009-12-17
US7838546B2 (en)	2010-11-23
ES2402782T3 (es)	2013-05-08
AU2011200408A1 (en)	2011-02-24
CA2820931A1 (en)	2008-01-24
WO2008010448A1 (en)	2008-01-24
PT2045244E (pt)	2013-04-15
EP2045244A4 (en)	2010-09-08
US20100234440A1 (en)	2010-09-16
MX2009000448A (es)	2009-01-27
HK1130060A1 (en)	2009-12-18
HK1173722A1 (en)	2013-05-24
EP2620431A1 (en)	2013-07-31
KR20130108487A (ko)	2013-10-02

Publication	Publication Date	Title
BRPI0813105A2 (pt)	2015-08-04	Derivado de sulfonamida de ácido malônico e uso faramacêutico do mesmo
CR10406A (es)	2009-01-27	Nueva forma cristalina vi de la agomelatina, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen
HUE039199T2 (hu)	2018-12-28	Glutaminsav heterodimerjei
DK2048941T3 (da)	2014-09-08	Fremgangsmåde til opdræt af rovmider
HRP20170222T1 (hr)	2017-04-07	Kristalni oblik karbamoil-cikloheksan derivata
EP2022767A4 (en)	2009-05-06	KRISTALLGLAS SUBJECT
DK2475372T4 (da)	2020-11-30	Fremgangsmåde til fremstilling af micro-RNA og dets terapeutiske anvendelse
EP2240017A4 (en)	2011-02-16	KETONKÖRPER AND KETONKÖRPERESTER AS FLUTFETTSENKENDE MEDIUM
ATE531720T1 (de)	2011-11-15	Aza-benzofuranylverbindungen und anwendungsverfahren dafür
EP1981526A4 (en)	2011-03-02	ADIPONECTIN FOR THE TREATMENT OF VARIOUS DISORDERS
DK2104737T3 (da)	2013-05-27	Funktioner og formål for let-7 mikro-RNAer
HRP20150003T1 (xx)	2015-03-13	Sastavi inhibitora dpp-iv
DE112007001307A5 (de)	2009-04-30	Mikrobiologische Herstellung von 3-Hydroxyisobuttersäure
BRPI0909464A2 (pt)	2019-09-24	indentificação e auntentificação utilzando marcações de material de cristal líquido
DK3279663T3 (da)	2021-10-18	Anvendelse af gelsolin til diagnosticering og behandling af inflammationssygdomme
ATE434620T1 (de)	2009-07-15	Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
DK2056807T3 (da)	2012-10-22	Behandling af inflammatoriske sygdomme
DE602007004699D1 (de)	2010-03-25	Aryl(thio)ether-Aryl-Polysiloxan-Zusammensetzung sowie Herstellungs- und Verwendungsverfahren dafür
PL2152256T3 (pl)	2015-03-31	Związki aktywujące telomerazę i sposoby ich zastosowania
DK2445912T3 (da)	2014-11-10	Ny forbindelse anvendelig til behandlingen af degenerative og inflammatoriske sygdomme
EP2079544A4 (en)	2012-09-05	ARSENIC ABSORBENT COMPOSITION AND METHODS OF USE
IL208979B (en)	2018-02-28	Humanized antibodies against human interferon-alpha
BRPI0913398A2 (pt)	2015-11-24	composição e métodos de adesivo para dentaduras
EP2130549A4 (en)	2012-04-25	SOLID FIBRINOGEN PREPARATION
DE602006004463D1 (de)	2009-02-05	Kristallform von asenapinmaleat